The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence
- PMID: 16507997
- PMCID: PMC1430273
- DOI: 10.1128/MCB.26.6.2202-2214.2006
The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence
Abstract
In primary mouse embryo fibroblasts (MEFs), oncogenic Ras induces growth arrest via Raf/MEK/extracellular signal-regulated kinase (ERK)-mediated activation of the p19ARF/p53 and INK4/Rb tumor suppressor pathways. Ablation of these same pathways causes spontaneous immortalization in MEFs, and oncogenic transformation by Ras requires ablation of one or both of these pathways. We show that Kinase Suppressor of Ras 1 (KSR1), a molecular scaffold for the Raf/MEK/ERK cascade, is necessary for RasV12-induced senescence, and its disruption enhances primary MEF immortalization. RasV12 failed to induce p53, p19ARF, p16INK4a, and p15INK4b expression in KSR1-/- MEFs and increased proliferation instead of causing growth arrest. Reintroduction of wild-type KSR1, but not a mutated KSR1 construct unable to bind activated ERK, rescued RasV12-induced senescence. On continuous culture, deletion of KSR1 accelerated the establishment of spontaneously immortalized cultures and increased the proportion of cultures escaping replicative crisis. Despite enhancing escape from both RasV12-induced and replicative senescence, however, both primary and immortalized KSR1-/- MEFs are completely resistant to RasV12-induced transformation. These data show that escape from senescence is not necessarily a precursor for oncogenic transformation. Furthermore, these data indicate that KSR1 is a member of a unique class of proteins whose deletion blocks both senescence and transformation.
Figures
Similar articles
-
Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation.Mol Cell Biol. 2014 Sep 15;34(18):3461-72. doi: 10.1128/MCB.01633-13. Epub 2014 Jul 7. Mol Cell Biol. 2014. PMID: 25002533 Free PMC article.
-
RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.Cancer Res. 2009 Mar 15;69(6):2588-98. doi: 10.1158/0008-5472.CAN-08-2312. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276382 Free PMC article.
-
C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.EMBO J. 2005 Sep 21;24(18):3301-12. doi: 10.1038/sj.emboj.7600789. Epub 2005 Aug 18. EMBO J. 2005. PMID: 16107878 Free PMC article.
-
[pRB, p53, p16INK4a, senescence and malignant transformation].Bull Cancer. 2004 May;91(5):399-402. Bull Cancer. 2004. PMID: 15281278 Review. French.
-
Unraveling human tumor suppressor pathways: a tale of the INK4A locus.Cell Cycle. 2004 May;3(5):616-20. Epub 2004 May 15. Cell Cycle. 2004. PMID: 15044859 Review.
Cited by
-
SOS1 and KSR1 modulate MEK inhibitor responsiveness to target resistant cell populations based on PI3K and KRAS mutation status.Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2313137120. doi: 10.1073/pnas.2313137120. Epub 2023 Nov 16. Proc Natl Acad Sci U S A. 2023. PMID: 37972068 Free PMC article.
-
Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells.Int J Mol Sci. 2023 Jul 23;24(14):11821. doi: 10.3390/ijms241411821. Int J Mol Sci. 2023. PMID: 37511580 Free PMC article.
-
Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species.Sci Adv. 2023 Feb 15;9(7):eadd7969. doi: 10.1126/sciadv.add7969. Epub 2023 Feb 15. Sci Adv. 2023. PMID: 36791195 Free PMC article.
-
Conformational control and regulation of the pseudokinase KSR via small molecule binding interactions.Methods Enzymol. 2022;667:365-402. doi: 10.1016/bs.mie.2022.03.039. Epub 2022 Apr 25. Methods Enzymol. 2022. PMID: 35525547 Free PMC article.
-
KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma.Biomark Res. 2022 Apr 25;10(1):25. doi: 10.1186/s40364-022-00361-9. Biomark Res. 2022. PMID: 35468812 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous